Terms: = Lung cancer AND IKZF1, LyF-1, 10320, ENSG00000185811, Q13422, Hs_54452, hIk-1, ZNFN1A1, IKAROS
22 results:
1. Cytotoxic Programming of CD4+ T Cells Is Regulated by Opposing Actions of the Related Transcription Factors Eos and Aiolos.
Jones DM; Tuazon JA; Read KA; Leonard MR; Pokhrel S; Sreekumar BK; Warren RT; Yount JS; Collins PL; Oestreich KJ
J Immunol; 2024 Apr; 212(7):1129-1141. PubMed ID: 38363226
[TBL] [Abstract] [Full Text] [Related]
2. Association of Wiskott-Aldrich syndrome protein (WASp) in epigenetic regulation of B cell differentiation in non-small-cell lung cancer (NSCLC).
Chandnani N; Mandal A; Gupta I; Mukherjee O; Rakshit S; Shanmugam G; George M; Sarkar K
Med Oncol; 2023 Dec; 41(1):28. PubMed ID: 38146020
[TBL] [Abstract] [Full Text] [Related]
3. Transcriptional Heterogeneity Overcomes Super-Enhancer Disrupting Drug Combinations in Multiple Myeloma.
Welsh SJ; Barwick BG; Meermeier EW; Riggs DL; Shi CX; Zhu YX; Sharik ME; Du MT; Abrego Rocha LD; Garbitt VM; Stein CK; Petit JL; Meurice N; Tafoya Alvarado Y; Fonseca R; Todd KT; Brown S; Hammond ZJ; Cuc NH; Wittenberg C; Herzog C; Roschke AV; Demchenko YN; Chen WD; Li P; Liao W; Leonard WJ; Lonial S; Bahlis NJ; Neri P; Boise LH; Chesi M; Bergsagel PL
Blood Cancer Discov; 2024 Jan; 5(1):34-55. PubMed ID: 37767768
[TBL] [Abstract] [Full Text] [Related]
4. Co-expression of Foxp3 and Helios facilitates the identification of human T regulatory cells in health and disease.
Morina L; Jones ME; Oguz C; Kaplan MJ; Gangaplara A; Fitzhugh CD; Kanakry CG; Shevach EM; Buszko M
Front Immunol; 2023; 14():1114780. PubMed ID: 37350974
[TBL] [Abstract] [Full Text] [Related]
5. Genomic characterisation of de novo EGFR copy number gain and its impact on the efficacy of first-line EGFR-tyrosine kinase inhibitors for EGFR mutated non-small cell lung cancer.
Xu Y; Yan J; Zhou C; Wu L; Wang H; Zhao J; Zhou M; Wang J; Zheng X; Zhang L; Jiang K; Zheng X; Miao Q; Wu S; Zou Z; Lian R; He Y; Chen R; Yang S; Li Y; Chen S; Lin G
Eur J Cancer; 2023 Jul; 188():81-89. PubMed ID: 37201385
[TBL] [Abstract] [Full Text] [Related]
6. IKZF4 acts as a novel tumor suppressor in non-small cell lung cancer by suppressing Notch signaling pathway.
Wang Y; Zhao H; He Y; Zhang P; Zeng C; Du T; Shen Q; Chen Y; Zhao S
Cell Signal; 2023 Jul; 107():110679. PubMed ID: 37044192
[TBL] [Abstract] [Full Text] [Related]
7. Transcription Factors Leading to High Expression of Neuropeptide L1CAM in Brain Metastases from lung Adenocarcinoma and Clinical Prognostic Analysis.
Feng X; Guan N; Xu E; Miao Y; Li C
Dis Markers; 2021; 2021():8585633. PubMed ID: 35003395
[TBL] [Abstract] [Full Text] [Related]
8. Pyrotinib combined with thalidomide in advanced non-small-cell lung cancer patients harboring HER2 exon 20 insertions (PRIDE): protocol of an open-label, single-arm phase II trial.
Ai X; Song Z; Jian H; Zhou Z; Chen Z; Yu Y; Li Z; Lu S
BMC Cancer; 2021 Sep; 21(1):1033. PubMed ID: 34530760
[TBL] [Abstract] [Full Text] [Related]
9. [Clinical analysis of 12 cases of acute myeloid leukemia complicated with synchronous primary solid tumor].
Mi RH; Dang HB; Chen L; Han YL; Wang MF; Zhang YL; Chen L; Li DB; Wei XD
Zhonghua Yi Xue Za Zhi; 2020 Nov; 100(42):3323-3327. PubMed ID: 33202495
[No Abstract] [Full Text] [Related]
10. ikaros is heterogeneously expressed in lung adenocarcinoma and is involved in its progression.
Zhao W; Chen TB; Wang H
J Int Med Res; 2020 Aug; 48(8):300060520945860. PubMed ID: 32787735
[TBL] [Abstract] [Full Text] [Related]
11. Downregulation of miR-4772-3p promotes enhanced regulatory T cell capacity in malignant pleural effusion by elevating Helios levels.
Yu WQ; Ji NF; Gu CJ; Sun ZX; Wang ZX; Chen ZQ; Ma Y; Wu ZZ; Wang YL; Wu CJ; Ding MD; Dai GH; Yao J; Jin RR; Huang M; Zhang MS
Chin Med J (Engl); 2019 Nov; 132(22):2705-2715. PubMed ID: 31725455
[TBL] [Abstract] [Full Text] [Related]
12. N160 of Aiolos Determines its DNA-Binding Activity.
Wang H; Xu Z; Du W; Lin Z; Liu Z
Anat Rec (Hoboken); 2019 Nov; 302(11):2014-2019. PubMed ID: 31251838
[TBL] [Abstract] [Full Text] [Related]
13. Overexpression of Aiolos promotes epithelial-mesenchymal transition and cancer stem cell-like properties in lung cancer cells.
Hung JJ; Kao YS; Huang CH; Hsu WH
Sci Rep; 2019 Feb; 9(1):2991. PubMed ID: 30816208
[TBL] [Abstract] [Full Text] [Related]
14. Casein Kinase II (CK2) as a Therapeutic Target for Hematological Malignancies.
Gowda C; Sachdev M; Muthusami S; Kapadia M; Petrovic-Dovat L; Hartman M; Ding Y; Song C; Payne JL; Tan BH; Dovat S
Curr Pharm Des; 2017; 23(1):95-107. PubMed ID: 27719640
[TBL] [Abstract] [Full Text] [Related]
15. Origin and Role of a Subset of Tumor-Associated Neutrophils with Antigen-Presenting Cell Features in Early-Stage Human lung cancer.
Singhal S; Bhojnagarwala PS; O'Brien S; Moon EK; Garfall AL; Rao AS; Quatromoni JG; Stephen TL; Litzky L; Deshpande C; Feldman MD; Hancock WW; Conejo-Garcia JR; Albelda SM; Eruslanov EB
Cancer Cell; 2016 Jul; 30(1):120-135. PubMed ID: 27374224
[TBL] [Abstract] [Full Text] [Related]
16. Large-Scale Exome-wide Association Analysis Identifies Loci for White Blood Cell Traits and Pleiotropy with Immune-Mediated Diseases.
Tajuddin SM; Schick UM; Eicher JD; Chami N; Giri A; Brody JA; Hill WD; Kacprowski T; Li J; Lyytikäinen LP; Manichaikul A; Mihailov E; O'Donoghue ML; Pankratz N; Pazoki R; Polfus LM; Smith AV; Schurmann C; Vacchi-Suzzi C; Waterworth DM; Evangelou E; Yanek LR; Burt A; Chen MH; van Rooij FJ; Floyd JS; Greinacher A; Harris TB; Highland HM; Lange LA; Liu Y; Mägi R; Nalls MA; Mathias RA; Nickerson DA; Nikus K; Starr JM; Tardif JC; Tzoulaki I; Velez Edwards DR; Wallentin L; Bartz TM; Becker LC; Denny JC; Raffield LM; Rioux JD; Friedrich N; Fornage M; Gao H; Hirschhorn JN; Liewald DC; Rich SS; Uitterlinden A; Bastarache L; Becker DM; Boerwinkle E; de Denus S; Bottinger EP; Hayward C; Hofman A; Homuth G; Lange E; Launer LJ; Lehtimäki T; Lu Y; Metspalu A; O'Donnell CJ; Quarells RC; Richard M; Torstenson ES; Taylor KD; Vergnaud AC; Zonderman AB; Crosslin DR; Deary IJ; Dörr M; Elliott P; Evans MK; Gudnason V; Kähönen M; Psaty BM; Rotter JI; Slater AJ; Dehghan A; White HD; Ganesh SK; Loos RJ; Esko T; Faraday N; Wilson JG; Cushman M; Johnson AD; Edwards TL; Zakai NA; Lettre G; Reiner AP; Auer PL
Am J Hum Genet; 2016 Jul; 99(1):22-39. PubMed ID: 27346689
[TBL] [Abstract] [Full Text] [Related]
17. Disease risk factors identified through shared genetic architecture and electronic medical records.
Li L; Ruau DJ; Patel CJ; Weber SC; Chen R; Tatonetti NP; Dudley JT; Butte AJ
Sci Transl Med; 2014 Apr; 6(234):234ra57. PubMed ID: 24786325
[TBL] [Abstract] [Full Text] [Related]
18. Systematic identification of trans eQTLs as putative drivers of known disease associations.
Westra HJ; Peters MJ; Esko T; Yaghootkar H; Schurmann C; Kettunen J; Christiansen MW; Fairfax BP; Schramm K; Powell JE; Zhernakova A; Zhernakova DV; Veldink JH; Van den Berg LH; Karjalainen J; Withoff S; Uitterlinden AG; Hofman A; Rivadeneira F; Hoen PAC'; Reinmaa E; Fischer K; Nelis M; Milani L; Melzer D; Ferrucci L; Singleton AB; Hernandez DG; Nalls MA; Homuth G; Nauck M; Radke D; Völker U; Perola M; Salomaa V; Brody J; Suchy-Dicey A; Gharib SA; Enquobahrie DA; Lumley T; Montgomery GW; Makino S; Prokisch H; Herder C; Roden M; Grallert H; Meitinger T; Strauch K; Li Y; Jansen RC; Visscher PM; Knight JC; Psaty BM; Ripatti S; Teumer A; Frayling TM; Metspalu A; van Meurs JBJ; Franke L
Nat Genet; 2013 Oct; 45(10):1238-1243. PubMed ID: 24013639
[TBL] [Abstract] [Full Text] [Related]
19. Ectopic ikaros expression positively correlates with lung cancer progression.
Zhang Z; Xu Z; Wang X; Wang H; Yao Z; Mu Y; Ma Z; Liu Z
Anat Rec (Hoboken); 2013 Jun; 296(6):907-13. PubMed ID: 23580163
[TBL] [Abstract] [Full Text] [Related]
20. Integrative genomic analyses on ikaros and its expression related to solid cancer prognosis.
Yang L; Luo Y; Wei J
Oncol Rep; 2010 Aug; 24(2):571-7. PubMed ID: 20596648
[TBL] [Abstract] [Full Text] [Related]
[Next]
